Investment Rating - The report rates the commercial drone industry with a strong growth outlook, projecting a market size increase from 131.44 billion RMB in 2025 to 306.97 billion RMB by 2029, with a compound annual growth rate (CAGR) of 23.62% [46]. Core Insights - The commercial drone industry focuses on creating commercial value and enhancing operational efficiency through specialized equipment and integrated solutions [4][5]. - The market growth is driven by technological advancements, cost-effectiveness, and the emergence of new application scenarios such as low-altitude logistics and cultural tourism [4][49]. - The industry is characterized by high technical barriers compared to consumer drones, with a focus on long-term service cooperation rather than one-time sales [11][14]. Industry Definition - Commercial drones are defined as unmanned aerial vehicles designed to provide specialized services to enterprises and institutions, focusing on commercial value creation rather than personal entertainment [5]. Industry Classification - The commercial drone industry can be categorized into various application scenarios, including aerial photography, logistics delivery, agricultural protection, inspection and surveying, medical rescue, commercial performances, and derived commercial services [6]. Industry Features - The core demand of commercial drones is centered on "commercial value transformation," with a focus on addressing customer pain points [12]. - The technology requirements are higher than those for consumer drones, necessitating customized configurations and integrated solutions [13]. - The transaction model leans towards long-term service agreements, enhancing customer retention and profitability through ongoing service fees [14]. Development History - The industry has evolved through three main phases: the nascent phase (1990-2011), the startup phase (2012-2017), and the rapid development phase (2018-present), with significant technological advancements and market validation occurring in each stage [15][19]. Industry Chain Analysis - The industry chain consists of three segments: upstream (core components and key technology supply), midstream (drone manufacturing), and downstream (industry applications and operational services) [21][22]. - Upstream developments include advancements in materials and energy sources, such as carbon fiber and hydrogen technology, which enhance drone performance and reduce costs [23][30]. - Midstream challenges include limitations in battery energy density and signal transmission technology, which affect operational efficiency [24][38]. - Downstream applications are primarily in agricultural protection and surveying, with logistics delivery showing significant growth potential [43][44]. Market Size and Growth Drivers - The commercial drone market is expected to grow significantly, with agricultural protection projected to reach 30.93 billion RMB by 2025, accounting for 25% of the overall market [48]. - New application scenarios, such as low-altitude logistics and environmental monitoring, are expected to inject vitality into the market [49]. - The rise of the "Drone as a Service" (DaaS) model is lowering entry barriers for small and medium enterprises, further expanding the market [50].

行业简报 1 研究框架 | ◆ | 中国银行大模型部署实践 | ---------- | 3 | | --- | --- | --- | --- | | | • 金融大模型发展现状 | ---------- | 3 | | | • 银行大模型招投标情况 | ---------- | 4 | | | • 应用落地主要场景 | ---------- | 5 | | | • 应用落地实践效果 | ---------- | 6 | | | • 优化路径分析 | ---------- | 7 | | | • 发展机遇 | ---------- | 8 | | ◆ | 业务合作 | ---------- | 9 | | ◆ | 方法论及法律声明 | ---------- | 10 | www.leadleo.com 400-072-5588 DeepSeek如何优化银行业的算力资源与运营效率 企业标签：DeepSeeK China Large Model Industry 中国大規模モデル産業 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另 行标明出处者除外）。 ...

Investment Rating - The report indicates a positive investment outlook for the allergic asthma drug industry in China, with a projected compound annual growth rate (CAGR) of 15.6% from 2024 to 2030, leading to a market size of 467 billion yuan by 2030 [5][9][11]. Core Insights - The current treatment landscape for allergic asthma includes a variety of therapies such as inhaled corticosteroids (ICS), allergen immunotherapy (AIT), and biologics targeting type 2 inflammation, suitable for moderate to severe cases [5][6]. - The market for allergic asthma drugs in China is expanding, driven by an increasing patient population exceeding 40 million and a growing demand for innovative treatments that focus on long-term control rather than just symptom relief [9][11]. - The report highlights the rapid development of biologics, with several monoclonal antibodies targeting IL-5, IL-4Rα, and TSLP showing promise in clinical trials, thus diversifying treatment options for severe asthma patients [12][22]. Summary by Sections Treatment Patterns - The treatment modalities for allergic asthma primarily consist of chemical drugs, allergen immunotherapy, and biologics. Biologics are particularly effective for patients with specific biomarkers [5][6]. Market Size and Growth - The Chinese allergic asthma drug market grew from 11.2 billion yuan in 2018 to an estimated 19.6 billion yuan in 2024, with a CAGR of 9.8%. It is expected to reach 46.7 billion yuan by 2030, reflecting a significant increase in demand due to a rising patient base and improved treatment awareness [9][11]. Drug Development - The report notes a diverse pipeline for new drug development in the allergic asthma sector, with multiple candidates in various clinical trial phases targeting different pathways, including IL-5 and TSLP [12][22]. Biologics Overview - Four classes of monoclonal antibodies have been approved for asthma treatment: anti-IgE, anti-IL-5, anti-IL-5R, and anti-TSLP. These biologics are recommended as add-on therapies for patients who remain uncontrolled on standard treatments [12][22]. Future Trends - The report anticipates a "demand upgrade-technology breakthrough-policy empowerment" phase for the allergic asthma drug market in China, aiming to create a comprehensive ecosystem for innovative treatments that cater to all patient demographics [11][12].

Investment Rating - The report provides a positive investment rating for the apparel industry, highlighting growth potential driven by government support, competitive pricing, and market expansion opportunities [4]. Core Insights - The apparel industry is undergoing a transformation characterized by the integration of technology and fashion, with e-commerce and live-streaming commerce significantly boosting market growth [4]. - China's apparel exports are expected to grow due to favorable government policies, price advantages, and competitive quality in the global market [4]. Industry Definition - The apparel industry encompasses clothing, footwear, and accessories, serving functions such as protection, decoration, and identification [5]. - Apparel can be categorized by gender into men's and women's clothing, each with distinct design and functional characteristics [6]. Industry Characteristics - High raw material costs dominate the cost structure, with raw materials accounting for 76.1% of costs in upstream suppliers and 60% in midstream manufacturing [6][7]. - The export market is diversified, with growth in traditional markets like the US and EU, while emerging markets show mixed results [7]. - The industry exhibits strong cyclicality, with retail sales closely tied to economic growth rates [8]. Development History - The apparel industry in China has evolved through four key stages: industrialization, OEM rise, globalization, and brand and technology upgrades, currently transitioning into a phase driven by national pride and technological innovation [9]. Industry Chain Analysis - The apparel industry chain includes upstream raw material production, midstream manufacturing, and downstream brand sales, with varying levels of bargaining power across segments [14][15]. - Midstream manufacturers face challenges in negotiating with upstream suppliers due to industry fragmentation, leading to lower average profit margins [15]. - Labor cost increases are prompting a shift of the apparel supply chain to Southeast Asian countries [16]. Market Size and Growth - The apparel market size grew from 1,918.03 billion RMB in 2019 to 2,074.29 billion RMB in 2023, with a projected CAGR of 2.15% from 2024 to 2028 [36]. - E-commerce penetration and live-streaming commerce are key drivers of market growth, with significant increases in online shopping users [38][39]. Export Market Dynamics - China's apparel exports are benefiting from a recovery in overseas demand due to loose monetary policies and economic recovery in major markets [40]. - The export market is characterized by structural differentiation, with varying performance across different regions and product categories [40]. Policy Support - Government policies aimed at upgrading the industry and promoting digitalization and innovation are expected to drive future growth in the apparel sector [41][42]. - The competitive pricing of Chinese apparel products is anticipated to enhance export growth, particularly in the context of rising demand for affordable quality products in international markets [42].

www.leadleo.com 中国新能源汽车行业调研简报 | 2025/07 报告标签：新能源汽车线束、定义与分类、技术进步、市场规模、竞争格局 2025年7月 报告提供的任何内容（包括但不限于数据、文字、图表、图像等）均系头豹研究院独有的高度机密性文件（在报告中另行标明出处者除外）。未经头豹 研究院事先书面许可，任何人不得以任何方式擅自复制、再造、传播、出版、引用、改编、汇编本报告内容，若有违反上述约定的行为发生，头豹研究 院保留采取法律措施、追究相关人员责任的权利。头豹研究院开展的所有商业活动均使用"头豹研究院"或"头豹"的商号、商标，头豹研究院无任何前述名 称之外的其他分支机构，也未授权或聘用其他任何第三方代表头豹研究院开展商业活动。 新能源汽车线束是一组电线、电缆、连接器和其他电气元件的集 合，用于连接和传输电力、数据和控制信号，以支持新能源汽车 的正常运行和性能。新能源汽车线束是汽车电气系统的关键组成 部分，尤其是在电动汽车和混合动力汽车中得到广泛应用。 新能源汽车线束可分为低压线束和高压线束。新能源汽车低压线 束与传统燃油车线束区别不大，新能源汽车发动机的消失，减少 发动机线束的使用，其主要差别 ...

Investment Rating - The report indicates a positive investment outlook for the automotive chip industry, driven by the growth of electric vehicles and advancements in autonomous driving technology [4]. Core Insights - The automotive chip market is expected to grow significantly, with projections indicating a market size increase from 66.692 billion yuan in 2020 to 171.181 billion yuan by 2025 [37]. - The demand for automotive chips is being propelled by the electrification of vehicles, with electric vehicles requiring approximately twice the number of chips compared to traditional vehicles, and L4 autonomous vehicles needing over ten times the number of chips [12][39]. - The report highlights a clear trend towards domestic chip production in China, with local companies rapidly advancing in the automotive chip sector due to supply chain vulnerabilities exposed by global chip shortages [13][49]. Industry Definition - Automotive chips, also known as vehicle-grade chips, are semiconductor integrated circuits specifically designed for automotive electronic systems, serving as core components of Electronic Control Units (ECUs) [5]. - The industry is characterized by high technical barriers, stringent certification processes, and a growing trend towards domestic production in response to global supply chain challenges [11][14]. Industry Characteristics - The report identifies three main characteristics of the automotive chip industry: 1. Electrification driving market demand growth [12] 2. Significant domestic replacement of imported chips [13] 3. High technical barriers due to rigorous certification requirements [14] Development History - The automotive chip industry has evolved through three main phases: 1. Emergence phase (1970-1999) focused on basic electronic control [16] 2. Initiation phase (2000-2009) marked by the rise of electric and intelligent vehicles [17] 3. Rapid development phase (2010-present) characterized by the integration of advanced processing units and the rise of AI technologies [19]. Industry Chain Analysis - The automotive chip industry chain consists of three segments: upstream (raw materials and equipment), midstream (chip design and manufacturing), and downstream (system integration and vehicle application) [20]. - Upstream segments are heavily reliant on global suppliers, with low domestic penetration in high-end materials and equipment [21]. - Midstream manufacturers are increasingly competitive, with local companies making significant strides in various chip categories [22]. - Downstream demand is surging due to the rapid growth of electric and smart vehicles, with significant increases in chip requirements for power modules and advanced driver-assistance systems [34]. Market Size and Growth - The automotive chip market is projected to grow from 66.692 billion yuan in 2020 to 171.181 billion yuan by 2025, driven by the increasing penetration of electric vehicles and advancements in autonomous driving technology [37][41]. - The report notes that the market is expected to maintain a high growth rate due to the ongoing transformation of the automotive industry towards electrification and intelligence [42]. Competitive Landscape - The report outlines a competitive landscape where domestic companies are rapidly increasing their market share, with a notable shift from less than 3% to approximately 15% in domestic chip production [49]. - Key players in the domestic market include BYD Semiconductor, Sinda Semiconductor, and Horizon Robotics, with each company demonstrating strong technical capabilities in their respective fields [50].

Investment Rating - The report indicates a positive investment outlook for the China cell therapy CDMO industry, highlighting its transition from technological exploration to large-scale commercialization [4]. Core Insights - The China cell therapy CDMO industry is at a critical stage of transitioning from technology exploration to large-scale commercialization, supported by favorable policies and increasing clinical pipeline activity [4]. - The industry is experiencing significant growth in demand due to the acceleration of clinical trials and product approvals, which is driving the need for CDMO services [21][26]. - The report emphasizes the importance of technological innovation and operational efficiency in enhancing the competitiveness of CDMO companies in the global market [12][29]. Summary by Sections Industry Overview - The CDMO industry is driven by high R&D costs and risks, with biotech companies emerging as key players supported by capital and policy initiatives [9]. - The industry is entering a golden development period, with a shift from scale expansion to a focus on technological depth and global expansion [10]. Demand Analysis - Global research output in cell therapy is continuously increasing, leading to higher demands for production processes and quality control [21]. - The approval of cell therapy products in China is accelerating, which enhances the demand for CDMO services to address complex production challenges [26]. Supply Analysis - CDMO companies are experiencing revenue growth with stable gross margins, indicating a strong technical drive and sustainable development capabilities [28]. - The industry is witnessing a significant differentiation, with leading companies maintaining market positions while smaller firms face structural challenges [29]. Capacity Expansion - The CDMO industry is entering a phase of large-scale capacity expansion, with multiple companies establishing new GMP production facilities to meet future commercial production demands [32][33]. Market Size Analysis - The cell therapy CDMO market is showing a clear growth trajectory, with projections indicating a significant increase in market size from 2025 to 2030 due to more pipelines entering late-stage clinical trials and commercialization [35][37].

Investment Rating - The report does not explicitly state an investment rating for the smartphone screen production industry Core Insights - The smartphone screen production industry is characterized by high technical barriers and a highly concentrated supply chain, with key materials and equipment dominated by a few international giants [4][12][14] - The market for flexible AMOLED displays is rapidly growing, with a significant increase in shipments and market share [15][40] - The industry is expected to see continued growth driven by advancements in display technologies, including foldable screens and micro-LEDs [42] Summary by Sections Industry Definition - The smartphone screen production process involves the transformation of raw materials like glass substrates, liquid crystal, OLED materials, and conductive layers into high-resolution display modules, requiring expertise in materials science, optics, and electronic engineering [5] Industry Classification - The industry can be classified by display technology (LCD, OLED, Micro-LED) and product form (flat screens, curved screens, foldable screens) [6][9][11] Industry Characteristics - High technical barriers exist due to the complexity of production processes and the need for precision equipment [13] - The supply chain is highly concentrated, with a few companies controlling the majority of the market share in key materials and equipment [14] Development History - The industry has evolved from early LCD technology to the current dominance of OLED and flexible displays, with significant technological breakthroughs expected in the future [16][20] Industry Scale - The market size of the smartphone screen production industry is projected to grow from 742.90 billion RMB in 2025 to 874.45 billion RMB by 2029, with a compound annual growth rate of 4.16% [38] Market Trends - The demand for AMOLED displays is increasing, with sales expected to reach 2,992 billion RMB by 2030, driven by their advantages in quality and energy efficiency [40] - The foldable screen market is also expanding, with a 53.1% year-on-year increase in shipments in Q1 2025 [42] Competitive Landscape - The industry is characterized by high concentration, with major players like Samsung, LG, and BOE leading the market [48][50] - Domestic manufacturers are rapidly increasing their market share, with BOE becoming a key supplier for major brands like Apple [50]

Investment Rating - The report indicates a strong investment outlook for the immune cell therapy products industry in China, projecting significant market growth and innovation opportunities [6][23]. Core Insights - The immune cell therapy market in China is experiencing rapid expansion, with the market size increasing from approximately 1.5 billion yuan in 2019 to nearly 5.5 billion yuan in 2023, and is expected to exceed 10 billion USD by 2030 [6][23]. - The industry is focusing on overcoming clinical challenges in solid tumor treatments, with innovative technologies like TCR-T and CAR-NK gaining traction [6][23]. - The regulatory environment is improving, with policies supporting the commercialization of cell therapies and encouraging the use of real-world data [6][20]. Summary by Sections Industry Overview - The immune cell therapy products are defined as biological agents made from activated or genetically modified immune cells, including CAR-T, TCR-T, and NK cells [15][17]. - The development of immune cell therapy in China has progressed through five stages: theoretical foundation, technological exploration, engineering breakthroughs, industrialization, and innovation [17][20]. Market Size - The global immune cell therapy market is projected to grow from 1.189 billion USD in 2019 to 4.353 billion USD in 2024, with a compound annual growth rate (CAGR) driven by breakthroughs in blood cancer treatments [23][24]. - China's market is expected to grow from 220 million USD in 2019 to 750 million USD in 2024, with a potential to surpass 10.85 billion USD by 2030 [23][24]. Industry Chain Analysis - The industry chain consists of upstream suppliers of raw materials and equipment, midstream R&D and production companies, and downstream medical institutions and patients [31][32]. - The cost structure in the upstream production process is shifting towards capital-intensive models, with raw material costs remaining a critical factor [35][38]. Development Trends - The industry is witnessing a surge in IND applications, with 58 approvals expected in 2024, marking a significant increase from previous years [39][41]. - The focus is shifting from homogeneous competition in target markets to breakthroughs in solid tumors and enhancing accessibility [39][42].

Investment Rating - The report does not explicitly state an investment rating for the exoskeleton robot industry Core Insights - The exoskeleton robot industry is experiencing rapid growth, with significant advancements in technology and increasing market demand across various sectors [21][16] - The market for consumer-grade exoskeleton robots is expanding, with notable products like the Mo/Go and EasyGo gaining popularity [3][4] - The industry is supported by government policies and increasing investment, indicating a positive outlook for future development [21][16] Summary by Sections Exoskeleton Robot Overview - Exoskeleton robots are wearable devices that enhance human capabilities, categorized into assistive and locomotion types [2] Market Trends and Consumer Products - The launch of consumer-grade exoskeletons, such as the Mo/Go and EasyGo, marks a shift towards mainstream adoption, with prices ranging from approximately $2,599 to $8,000 [3][4][15] - The rental model for exoskeletons is emerging, making them more accessible to consumers [16] Application Fields - Exoskeleton robots are being utilized in various sectors, including rehabilitation, industrial assistance, outdoor sports, and military applications [8][9][10] - In the rehabilitation sector, exoskeletons can significantly improve recovery efficiency and reduce muscle atrophy risks [8] - In industrial settings, they enhance worker productivity and safety, with examples from logistics and manufacturing [9] Pricing Dynamics - Consumer-grade exoskeletons are priced between 6,000 to 8,000 yuan, while industrial models can range from tens of thousands to over a million yuan depending on complexity and customization [15][16] Investment and Financing - The exoskeleton robot industry in China is witnessing a surge in financing activities, with multiple funding rounds occurring in 2025, indicating a diverse range of investors [21][22] - Notable financing events include significant investments in companies like Aoshark and Cheng Tian Technology, aimed at product diversification and technological advancements [21][22]